Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Berlin - Delayed Quote • EUR Galapagos NV (GXE.BE) Follow Add holdings 23.04 +0.62 +(2.77%) At close: April 24 at 7:33:06 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for GXE.BE 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: GXE.BE View More All News Press Releases SEC Filings Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts Galapagos Announces Executive Leadership Updates Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025 Is Galapagos (GLPG) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? Biotech stocks slide as Marks resignation seen being negative for sector Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting Galapagos to Present at Upcoming Investor Conferences Galapagos (AMS:GLPG) adds €185m to market cap in the past 7 days, though investors from five years ago are still down 89% Galapagos receives transparency notification and 13D filing from Tang Capital Galapagos NV (GLPG) (FY 2024) Earnings Call Highlights: Strategic Shifts and Financial Resilience Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update Related Tickers BVXP.L Bioventix PLC 2,500.00 0.00% GMAB.CO Genmab A/S 1,340.00 +0.75% CPRX Catalyst Pharmaceuticals, Inc. 23.19 +0.30% REGN Regeneron Pharmaceuticals, Inc. 599.76 +2.03% BNTX BioNTech SE 120.54 +4.97% VRTX Vertex Pharmaceuticals Incorporated 492.47 +0.01%